This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bank of America's Moynihan May Head Back for Countrywide Testimony

BTIG analyst Mark Palmer stated in a recent research note that he has "heard variations on a theory that Bank of America intends to drag out its litigation with MBIA until the bond insurer's structured finance unit exhausts its liquidity."

However, Palmer thinks that would take until mid-2013.

"Does Bank of America really want to go through a full year during which more and more damaging information about Countrywide could emerge through discovery, and nasty precedents could be handed down in Bransten's courtroom?" Palmer asks in his report.

Palmer doesn't think so. Rather, he believes Bank of America will eventually settle the case for $2-3 billion--a view that is the key to his recommendation of MBIA shares.

Still, Bank of America has already allowed the case to drag on much farther than Palmer would have expected.

"We have struggled to understand Bank of America's overall strategy regarding MBIA, particularly given our view that it would be imprudent for the bank to continue the litigation given the consequences of allowing information and precedents from the case to be used by many other plaintiffs to advance their own cases against Countrywide," Palmer wrote.

A call and an email message to a Bank of America spokesman were not returned. An MBIA spokesman declined to comment.

-- Written by Dan Freed in New York.

Follow this writer on Twitter.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
MBI $9.00 -1.00%
BAC $16.74 1.50%
TSLA $247.43 -0.01%
YHOO $43.39 1.30%
AAPL $132.03 1.90%

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,125.67 +21.47 1.02%
NASDAQ 5,109.4530 +76.7020 1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs